Purdue Research Park-based life sciences firm receives $300,000 NIH grant
November 13, 2012
WEST LAFAYETTE, Ind. - A life sciences company whose technology could help researchers develop drug candidates to battle cancer, diabetes, and immune system and neurological disorders has received a $300,000 grant from the National Institutes of Health.
Tymora Analytical Operations LLC, a Purdue Research Park-based company, received the SBIR Phase I grant to optimize and strengthen its PolyMAC product. The technology promotes the discovery of new disease targets in laboratory settings. It is based on research by W. Andy Tao, associate professor in Purdue's Department of Biochemistry. The company licensed the technology through the Purdue Office of Technology Commercialization.
Anton Iliuk, president and chief technology officer, said PolyMAC could help determine whether a potential drug in development is focused on the intended disease targets. He described how the NIH funding will benefit Tymora Analytical Operations' efforts.
"Products currently available on the market typically see only the tip of the iceberg of a disease," he said. "PolyMAC technology allows a researcher to dive deeper into the complicated disease network to find the most optimal and promising treatment targets."
Iliuk said the company's focus is to strengthen efforts in university and industrial laboratories to find more effective, efficient drug treatment candidates for cancer, immunological and infectious illnesses, and diabetes.
Tymora Analytical Operations received a $150,000 SBIR Phase I grant from the NIH to develop an application for its pIMAGO platform earlier in 2012. It also received a $150,000 SBIR Phase I grant from the National Science Foundation in 2011, and $20,000 from the Purdue-administered Emerging Innovations Fund in 2012.
About Tymora Analytical Operations LLC
Tymora Analytical Operations was established in 2010 to provide new nanotechnology-based products to serve the R&D market in the life sciences. Tymora has developed a nanoscale platform technology - with PolyMAC and pIMAGO as the lead products - for unmet needs in the analysis of protein phosphorylation that relates to the onset of numerous diseases, most notably cancer.
About Purdue Research Park
The Purdue Research Park, with four locations across Indiana, has the largest university-affiliated business incubation complex in the country. The park network is home to about 200 companies that employ 4,000 people and are located in West Lafayette, Indianapolis, Merrillville and New Albany.
Purdue Research Park contact: Steve Martin,
Source: Anton Iliuk, 765-490-6834, email@example.com